According to Galectin Therapeutics's latest financial reports the company has -$60.25 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $-32.2 M | -1330.66% |
2021-12-31 | $2.61 M | -89.19% |
2020-12-31 | $24.19 M | -46.94% |
2019-12-31 | $45.59 M | 560.99% |
2018-12-31 | $6.89 M | 478.21% |
2017-12-31 | $1.19 M | -90.07% |
2016-12-31 | $12.01 M | -52.03% |
2015-12-31 | $25.04 M | -10.46% |
2014-12-31 | $27.97 M | 240.03% |
2013-12-31 | $8.22 M | 3.92% |
2012-12-31 | $7.91 M | 80.05% |
2011-12-31 | $4.39 M | -359.56% |
2010-12-31 | $-1.7 M | -62.08% |
2009-12-31 | $-4.47 M | 852.45% |
2008-12-31 | $-0.47 M | -83.96% |
2007-12-31 | $-2.93 M | 13190.91% |
2006-12-31 | $-0.03 M | -100.61% |
2005-12-31 | $3.58 M | -64.54% |
2004-12-31 | $10.1 M | 32.54% |
2003-12-31 | $7.62 M | 371.67% |
2002-12-31 | $1.61 M | 32.94% |
2001-12-31 | $1.21 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Mirati Therapeutics MRTX | $0.94 B | -1,671.13% | ๐บ๐ธ USA |
MannKind Corp MNKD | -$0.25 B | 308.64% | ๐บ๐ธ USA |